BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2018
View Archived Issues
AdAlta redesigns lead candidate for idiopathic pulmonary fibrosis
Read More
Biogen and Ionis expand strategic collaboration
Read More
IMPACT 1 and IMPACT 2 trial results lead to cadazolid's discontinuation
Read More
Clementia begins MO-Ped study of palovarotene
Read More
Merck & Co. patents novel mGlu2 receptor negative allosteric modulators
Read More
Vanderbilt University describes new WDR5/MLL1 interaction inhibitors
Read More
Novel CFTR modulators divulged by Vertex Pharmaceuticals
Read More
Sichuan Kelun-Biotech Biopharmaceutical discovers new FXR agonists
Read More
EMA grants orphan drug designation for ABO-202 gene therapy program in Batten disease
Read More
First efficacy and safety data presented from the RESTORE-IMI 1 phase III trial
Read More
Daiichi Sankyo discovers novel proto-oncogene tyrosine-protein kinase receptor Ret inhibitors
Read More
Novel calpain inhibitors identified at Blade Therapeutics
Read More
Patient enrollment ongoing in phase I study of ANX-007 in primary open-angle glaucoma
Read More
Primary endpoint not met in Arpeggio study of laquinimod in primary progressive multiple sclerosis
Read More
FDA approves intravenous Akynzeo
Read More
Farnesoid X receptor agonist EYP-001 safe and well tolerated in HBV-infected patients
Read More
New phase II trial explores GS-9131 functional monotherapy in HIV-1 patients failing NRTI regimen
Read More
Fujifilm studies FF-10832 in phase I trial for advanced solid tumors
Read More
Lilly reports further data from phase III RANGE study of Cyramza in advanced urothelial carcinoma
Read More
GlaxoSmithKline presents novel hSTING agonist GSK-532
Read More
FDA clears use of Bruker Maldi Biotyper CA system to identify C. auris
Read More
Novartis files for approval of tisagenlecleucel in Japan
Read More
Fresenius decides to terminate merger agreement with Akorn
Read More
TesoRx conducts pilot study of TSD-001 for low-grade stage Ta non-muscle invasive bladder cancer
Read More